FRONTIERS IN STEM CELLS IN CANCER (FriSC2), an annual advanced training course, trains promising physician and scientists from predominately underrepresented communities in sophisticated technologies using pluripotent stem cells for clinically relevant discoveries in cancer. The purpose of this training course is to provide comprehensive and sophisticated training in research strategies and state-of-the-art methods on cellular, molecular and genetic approaches for advancing Cancer Stem Cell Research.
This NIH sponsored course trains pre- and postdoctoral trainees, independent scientists, physicians, and established investigators seeking comprehensive and sophisticated training in research strategies and state-of-the-art cellular, molecular and genetic approaches for advancing cancer research. The course includes a complete array of biological and medical perspectives from the basic biology of “stemness” through preclinical and clinical trials evaluating the ‘cancer stem cell’ hypothesis and advanced diagnostics along with therapeutic insights afforded by “hands-on” experience investigating stem cells.
FriSC2 is a dynamic advanced training course that offers a fresh series of daily lectures on emerging concepts, followed by discussion and laboratory research over a week period. The participants garner the necessary knowledge of laboratory techniques, career mentoring and the ethical-legal-societal impact of cancer and stem cell research and allows them to apply their recently-acquired knowledge of cancer and stem cells to their specific research project. These courses are offered at Morehouse School of Medicine in Atlanta, GA and Ponce Health Sciences University in Ponce, PR.